Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer

Fonte Standard Gras
Identifiant

Unité de recherche

INNOSUISSE

Numéro de projet

17239.1;4 PFLS-LS

Titre du projet

Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer: MIP: AIDD

Titre du projet anglais

Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer: MIP: AIDD

Textes relatifs à ce projet

	Allemand	Français	Italien	Anglais
Description succincte	-	-	-
Résumé des résultats (Abstract)	-	-	-

Textes saisis

Catégorie	Texte
Description succincte (Anglais)	Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer
Résumé des résultats (Abstract) (Anglais)	This project represents an approach towards a first-in-class treatment of Triple Negative Breast Cancer (TNBC). AIDD together with UNIL and UNIGE will target small molecule inhibitors of the FZD7 receptor, a novel target for the treatment of TNBC. Assay development and high throughput screening followed by a small molecule optimization process will generate a proof of concept data package capable of attracting partners from the pharmaceutical industry.

Catégorie

Texte

Description succincte
(Anglais)

Small molecule inhibitors of FZD7 Receptor (Frizzled 7) for treatment of triple negative breast cancer

Résumé des résultats (Abstract)
(Anglais)

This project represents an approach towards a first-in-class treatment of Triple Negative Breast Cancer (TNBC). AIDD together with UNIL and UNIGE will target small molecule inhibitors of the FZD7 receptor, a novel target for the treatment of TNBC. Assay development and high throughput screening followed by a small molecule optimization process will generate a proof of concept data package capable of attracting partners from the pharmaceutical industry.